South Korea Womens Healthcare Market Size, Share, and COVID-19 Impact Analysis, By Indication (Postmenopausal Osteoporosis, Infertility, Reproductive Health Management, Polycystic Ovary Syndrome, Gynecologic Cancer, and Others), By Diagnosis (Bone Densitometry, Diagnostic Imaging Tests, Biopsies, Ovulation Testing, and Others), and South Korea Women’s Healthcare Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareSouth Korea Womens Healthcare Market Insights Forecasts to 2035
- The South Korea Womens Healthcare Market Size was estimated at USD 382.0 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 6.1% from 2025 to 2035
- The South Korea Women's Healthcare Market Size is Expected to Reach USD 733.0 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, the South Korea Women's Healthcare Market is anticipated to reach USD 733.0 million by 2035, growing at a CAGR of 6.1% from 2025 to 2035. Increasing government support, prevalence of chronic diseases, and health awareness. The need for specialized services is being driven by aging populations, a greater emphasis on preventive care, and easier access to diagnostic tools.
Market Overview
The South Korea women's healthcare market refers to the entire ecosystem of goods, services, and technology created to meet the unique health requirements of women at every stage of life is referred to as the South Korean women's healthcare market. Additionally, opportunities in the field of women's healthcare are growing, especially in fields like mental health services, maternal care, and reproductive health. Telemedicine is being used by the South Korean government as a means of implementing policy changes to enhance the health of women. Wearables and mobile health apps are two examples of innovative technologies that are expanding women's access to timely health care and monitoring. The digitalization of women's healthcare has advanced with the recent surge in activity on online portals for health education and consultation. This is particularly noticeable in urban areas where access to traditional healthcare services is restricted due to hectic schedules. These services have the potential to greatly benefit such individuals. Furthermore, the demand for specialized mental health services, which are starting to be acknowledged as a critical component of overall women's healthcare, is also being driven by the rising prevalence of mental health awareness among women. Therefore, as South Korea adopts a more holistic approach to women's health, it creates opportunities for creative solutions and healthcare delivery strategies that can be tailored to the particular requirements of women.
Report Coverage
This research report categorizes the market for the South Korea women's healthcare market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea women's healthcare market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea women's healthcare market.
South Korea Womens Healthcare Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 382.0 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 6.1% |
2035 Value Projection: | USD 733.0 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 220 |
Tables, Charts & Figures: | 114 |
Segments covered: | By Indication, By Diagnosis and COVID-19 Impact Analysis |
Companies covered:: | Hanmi Pharmaceutical, Dong A ST Co. Ltd, Ildong Pharmaceutical Co. Ltd, Chong Kun Dang Pharmaceutical Corp, Hana Pharm Co. Ltd, Others. |
Pitfalls & Challenges: | Covid 19 Impact Challenges, Future, Growth and Analysis |
Get more details on this report -
Driving Factors
A confluence of social, economic, and technological factors is currently driving notable trends in the South Korean women's healthcare market. A major factor propelling the market is the growing focus and awareness of women's health issues, particularly in light of the rising prevalence of chronic illnesses and conditions unique to women, like breast and cervical cancers. Programs to improve women's health services are being implemented by government initiatives and healthcare providers in response to the aging population and the trend toward preventive care.
Restraining Factors
The adverse effects of some treatments, the lack of insurance coverage, and the lack of awareness in rural areas are the main obstacles facing the South Korean women's healthcare market.
Market Segmentation
The South Korea women's healthcare market share is classified into indication and diagnosis.
- The postmenopausal osteoporosis segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea women's healthcare market is segmented by indication into postmenopausal osteoporosis, infertility, reproductive health management, polycystic ovary syndrome, gynecologic cancer, and others. Among these, the postmenopausal osteoporosis segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Given the growing awareness of women's bone health, the need for efficient osteoporosis management solutions has increased as more South Korean women reach postmenopausal ages.
- The diagnostic imaging tests segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea women's healthcare market is segmented by diagnosis into bone densitometry, diagnostic imaging tests, biopsies, ovulation testing, others. Among these, the diagnostic imaging tests segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Mammography and ultrasound are examples of diagnostic imaging tests that offer vital information for identifying anomalies and enabling prompt interventions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea women's healthcare market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Hanmi Pharmaceutical
- Dong A ST Co. Ltd
- Ildong Pharmaceutical Co. Ltd
- Chong Kun Dang Pharmaceutical Corp
- Hana Pharm Co. Ltd
- Others
Recent Developments:
- In Jully 2025, Femtech enhanced healthcare solutions for women through innovative technology and AI advances.
Key Target Audience
- Market Players
- Investors
- End users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value Added Resellers (VARs)
Market Segment
This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Women's Healthcare Market based on the below-mentioned segments:
South Korea Women's Healthcare Market, By Indication
- Postmenopausal Osteoporosis
- Infertility
- Reproductive Health Management
- Polycystic Ovary Syndrome
- Gynecologic Cancer
- Others
South Korea Women's Healthcare Market, By Diagnosis
- Bone Densitometry
- Diagnostic Imaging Tests
- Biopsies
- Ovulation Testing
- Others
Need help to buy this report?